UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): July 14, 2005
Senesco Technologies, Inc.
(Exact Name of Registrant as Specified in Charter)
|
Delaware |
|
001-31326 |
|
84-1368850 |
||
|
(State or Other Jurisdiction |
|
(Commission File Number) |
|
(IRS Employer Identification No.) |
||
|
|
|
|
|
|
||
|
303 George Street, Suite 420, New Brunswick, New Jersey |
|
08901 |
||||
|
(Address of Principal Executive Offices) |
|
(Zip Code) |
||||
|
|
|
|
||||
|
(732) 296-8400 |
||||||
|
(Registrant’s telephone number, |
||||||
|
|
|
|
|
|
||
|
Not applicable |
||||||
|
(Former Name or Former Address, if Changed Since Last Report) |
||||||
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425).
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12).
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)).
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).
Item 7.01. Regulation FD Disclosure.
On July 14, 2005, Senesco Technologies, Inc., a Delaware corporation (the “Company”), issued a press release to report the results of a pre-clinical lung cancer study in mice.
The full text of the press release is attached to this current report on Form 8-K as Exhibit 99.1.
The information in this Form 8-K and the press release shall be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and this Form 8-K shall be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”) and the Exchange Act.
Item 9.01. Financial Statements and Exhibits.
(c) Exhibits.
|
Exhibit No. |
|
Description |
|
|
|
|
|
99.1 |
|
Press Release of Senesco Technologies, Inc. dated July 14, 2005. |
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
|
|
SENESCO TECHNOLOGIES, INC. |
||
|
|
|
||
|
|
|
||
|
Dated: July 15, 2005 |
By: |
/s/ Bruce Galton |
|
|
|
|
Name: Bruce Galton |
|
|
|
|
Title: President and Chief Executive Officer |
|
3